“E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease”
This study is designed to enhance the understanding of the possible health effects of e-cigarette use by relating the acute and long-term use of e-cigarettes and conventional cigarettes ("products") to well-validated cardiovascular and pulmonary disease biomarkers. Participants will be enrolled in 4 groups: exclusive e-cigarette users, exclusive cigarette smokers, e-cigarette and cigarette users, and a control group of never-users. Participants can expect up to 4 weeks of study participation.
Behavioral - Cigarettes
Behavioral - E-Cigarettes
E-cigarette usage >/= 5 days/week
E-Cigarette Effects on Markers of Cardiovascular and Pulmonary Disease Risk (Aka CLUES - Cardiac and LUng E-cig Smoking Study)